Sotera Health (SHC) Debt to Equity (2020 - 2026)
Sotera Health (SHC) debt to equity from Dec 31, 2020 to Mar 31, 2026. The current Sotera Health (SHC) debt to equity is 343.50%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Sotera Health (SHC)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 353.23% | -35.66% |
| 2024 | 548.99% | +9.31% |
| 2023 | 502.21% | -9.53% |
| 2022 | 555.11% | +86.61% |
| 2021 | 297.48% | -26.27% |
| 2020 | 403.45% | N/A |
Comparison Sotera Health (SHC) debt to equity with competitors
Sotera Health (SHC) debt to equity is 343.50%.
| Ticker | Name | Debt to Equity | Upside |
|---|---|---|---|
| CRL | Charles River Laboratories International Inc | 0.23% | -99.93% |
| OPK | Opko Health Inc | 0.29% | -99.91% |
| PRPO | Precipio Inc | 0.49% | -99.86% |
| CSTL | Castle Biosciences Inc | 2.18% | -99.36% |
| NTRA | Natera Inc | 4.53% | -98.68% |
| APDN | Applied Dna Sciences Inc | 4.60% | -98.66% |
| DGX | Quest Diagnostics Inc | 6.83% | -98.01% |
| PRPH | ProPhase Labs Inc | 7.54% | -97.81% |
| BLLN | Billiontoone Inc - Class A | 17.80% | -94.82% |
| IDXX | Idexx Laboratories Inc | 28.91% | -91.58% |
| ICLR | Icon Plc | 31.25% | -90.90% |
| WAT | Waters Corp | 31.75% | -90.76% |
| DHR | Danaher Corp | 34.91% | -89.84% |
| MYGN | Myriad Genetics Inc | 35.66% | -89.62% |
| WGS | GeneDx Holdings Corp - Class A | 38.06% | -88.92% |
| NEO | Neogenomics Inc | 40.86% | -88.10% |
| QGEN | Qiagen NV | 43.79% | -87.25% |
| RVTY | Revvity Inc | 44.66% | -87.00% |
| A | Agilent Technologies Inc | 47.11% | -86.29% |
| ADPT | Adaptive Biotechnologies Corp | 60.35% | -82.43% |
| LH | Laboratory Corp Of America Holdings | 72.57% | -78.87% |
| TMO | Thermo Fisher Scientific Inc | 88.65% | -74.19% |
| RDNT | Radnet Inc | 100.55% | -70.73% |
| XGN | Exagen Inc | 158.47% | -53.86% |
| IQV | IQVIA Holdings Inc | 254.51% | -25.91% |
| NOTV | Inotiv, Inc. Common Stock | 532.33% | +54.97% |
| BDSX | Biodesix Inc | 547.55% | +59.40% |